Abstract
Rutin is a functional compound with both antioxidant and anti-cancer properties. The hydrolysis of rutin glycosides by intestinal bacteria is important for rutin absorption. We isolated Enterococcus sp. rutin_18, an intestinal bacterium that can convert rutin to quercetin, and investigated the possibility of Enterococcus sp. rutin_18-mediated rutin conversion to quercetin in vivo using mono-associated mice. We compared the plasma and cecal quercetin levels in rutin-metabolizing Enterococcus sp. rutin_18 mono-associated (Entero) and germ-free (GF) mice fed a rutin-supplemented diet. The plasma quercetin, isorhamnetin, and tamarixetin concentrations were significantly higher in the Entero mice than in the GF mice. The cecal rutin concentration was significantly lower in the Entero mice than in the GF mice (p<0.001). We found that Enterococcus sp. rutin_18 converted rutin to quercetin in the Entero mice. We infer that the Enterococcus sp. rutin_18 used in this study is an important intestinal bacterium that converts rutin to quercetin.